MASSACHUSETTS GENERAL HOSPITAL
Department of Pharmacy
Department of Nursing
Critical Care
Generic Name: |
Naloxone |
Trade Name: |
Narcan |
Action: |
Opiate Antagonist |
Indications: |
Reversal of respiratory depression induced by opiates |
Administration Guidelines: |
|
Usual Dosage Range and Route: |
0.4 - 2 mg IVP AT 2 to 3 minutes intervals as titrated to patient response for known narcotic overdose up to a maximum of 10 mg |
Standard Concentration: * |
MICROINFUSION: 20mg/50ml (0.4mg/ml) |
EW Standard |
20mg/ 50mL(0.4mg/ml) |
Special Considerations: |
*Naloxone infusions should be reserved for those patients who have a documented narcotic overdose of a long acting opiate and have responded to higher doses of intermittent IV boluses. Maintenance rates are 0.5 to 1.2 mg / hour. For further information, please contact the Pharmacy. *Naloxone infusions may be used for side effects associated with epidural administration of narcotics. Consult the Pain Service for details. -For the management of an unconscious victim, naloxone 2 mg can be used in conjunction with thiamine 100 mg ivp and dextrose 25 g ivp. |
Precautions and Side Effects: |
- Severe withdrawal symptoms - Hypertension - Tachycardia - Nausea, vomiting |
rev: 04/08